Clinical Trials Sponsored by Infectious Disease Hospital of Wuhai

Total 4905 results

National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant

Influenza A Virus, H7N9 Subtype

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age

Dengue

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Respiratory Syncytial Virus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers

Cytomegalovirus Infection

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus

Influenza, Human

United States
National Institute of Allergy and Infectious Diseases...

Completed

Cefixime / Azithromycin pK Study

Gonorrhoea

United States
National Institute of Allergy and Infectious Diseases...

Completed

Metabolic Effects of Non-Thymidine Analogue Anti-HIV Medications

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza Antiviral DAS-181-F04 in Healthy Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

SCOT Scleroderma Treatment Alternative Registry (STAR Registry)

Sclerosis | Scleroderma, Systemic

United States
National Institute of Allergy and Infectious Diseases...

Completed

Live Lung Donor Cross-sectional Cohort Study

Lung Transplantation

United States
National Institute of Allergy and Infectious Diseases...

Completed

Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea

Gonorrhoea

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age

West Nile Virus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Hemorrhagic Fever, Ebola

United States
National Institute of Allergy and Infectious Diseases...

Completed

Immune Response to Varicella Vaccination in Children With Atopic Dermatitis

Atopic Dermatitis

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Kidney Failure, Chronic

United States
National Institute of Allergy and Infectious Diseases...

Completed

An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens

Kidney Transplantation | End-Stage Renal Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

ZOSTAVAX® in Renal Transplant Patients

Herpes Zoster

United States
National Institute of Allergy and Infectious Diseases...

Completed

Chloroquine for Malaria in Pregnancy

Malaria

Malawi
National Institute of Allergy and Infectious Diseases...

Completed

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine

Dengue

United States
National Institute of Allergy and Infectious Diseases...

Completed

Heterosexual HIV Transmission Study (HATS)

HIV Infections | Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects

Pseudomonas Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Pulmonary Tuberculosis | Multidrug Resistant Tuberculosis | Extensively Drug Resistant Tuberculosis

Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine

H5N1 Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru (HVTN 914)

HIV Infections | Acquired Immunodeficiency Syndrome | RNA Virus Infections | Virus Diseases | Sexually Transmitted Diseases, Viral | Sexually Transmitted Diseases | Lentivirus Infections | Retroviridae Infections | Immunologic Deficiency Syndromes | Immune System Diseases | Slow Virus Diseases
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults

Dengue

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Monitor Patients With Primary or Early HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine

Dengue

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

High Dose Influenza in Immunosuppressed Subjects

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

Genomics of Chronic Renal Allograft Rejection (The GoCAR Study)

Kidney Transplantation

United States, Australia
National Institute of Allergy and Infectious Diseases...

Withdrawn

A Study of Patients Who Recently Have Been Infected With HIV

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Increasing HAART-Induced Immune Restoration With Cyclosporine

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

TIV and High Dose TIV in Subjects With Rheumatoid Arthritis

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Eldery High Dose TIV 2005

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Combination Study With MVA BN and Dryvax

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Caspofungin Study for Fungal Infections in Adults in Critical Care Settings

Candidiasis

United States
National Institute of Allergy and Infectious Diseases...

Completed

FLU-VACS Comparative Study in Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

9-valent CRM 197 Pneumococcal

Pneumococcal Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

HIV Infections | AIDS-Related Opportunistic Infections

United States, Puerto Rico, South Africa
National Institute of Allergy and Infectious Diseases...

Withdrawn

Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age

Influenza
National Institute of Allergy and Infectious Diseases...

Completed

Leprosy Skin Test Antigens Phase 1

Leprosy
National Institute of Allergy and Infectious Diseases...

Completed

Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso

Malaria

Burkina Faso

Clinical Trials Sponsored by Infectious Disease Hospital of Wuhai

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations